Advertisement Nerites raises $5.7 million in series A financing - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Nerites raises $5.7 million in series A financing

Nerites, a company that develops novel tissue repair products and coatings for medical devices, has completed $5.7 million series A round of funding.

Venture Investors of Madison, Wisconsin, with participation by Black Mountain Ventures of Foster City, California, led the investment. The company will use the funding to refine product development plans, begin product development and expand its business development plan for bringing the first tissue adhesive products on to the market.

Thomas Mozer, CEO and president of Nerites, said: “This funding will allow us to focus and accelerate development of applications for a handful of strategically chosen markets that represent tremendous investment opportunities and have a need for our breakthrough tissue adhesive technology.”